General Archive

  • News releases

    MRC Technology calls for diagnostic collaboration

    MRC Technology is inviting potential partners with early stage RNA, DNA and/or protein-based diagnostics to submit details and explore collaborative…

    Read more

  • News releases

    MRC Technology welcomes launch of Knowledge Quarter

    MRC Technology is a member of the newly launched Knowledge Quarter, set up to create a vibrant knowledge hub by…

    Read more

  • News releases

    MRC Technology and Shandong International Biotechnology Park (China) to cooperate in new drug for Alzheimer’s

    MRC Technology and Shandong International Biotechnology Park (BIOasis) have signed a partnership agreement for the development of a new Alzheimer’s…

    Read more

  • News releases

    MRC Technology and Yabao Pharmaceuticals Announce Exclusive Partnership in China to Develop Novel Therapeutics for Parkinson’s Disease

    New partnership with Yabao Pharmaceutical Co, Inc. to discover, develop and commercialise innovative compounds targeting a specific kinase involved in…

    Read more

  • News releases

    Charities pledge to jump start drug development for brain diseases

    The Neurodegeneration Medicines Acceleration Programme (Neuro-MAP), led by medical research charity MRC Technology, will see charities and funding bodies identify…

    Read more

  • News releases

    Catherine Kettleborough elected to SLAS Europe Council

    Congratulations to Catherine Kettleborough, MRC Technology’s Associate Director of Drug Discovery Biology, who has been elected to the SLAS Europe…

    Read more

  • News releases

    MRC Technology and Proximagen Collaborate to Develop Novel Therapeutics for Inflammatory and Autoimmune Disease

    Project will investigate a small molecule solution for Macrophage migration inhibitory factor

    Read more

  • News releases

    Dr. John Stageman Appointed Chair of the Board for MRC Technology

    London, UK, 29 September 2014: MRC Technology (MRCT), a UK medical research charity, today announced the appointment of Dr. John…

    Read more

  • News releases

    Breakthrough Melanoma Treatment, Keytruda, Developed Using Antibody Humanization Expertise at UK’s MRC Technology

    MRC Technology is pleased to highlight that today Merck, known as MSD outside the United States and Canada, announced FDA…

    Read more

  • News releases

    MRC Technology Announces Humanization of Anti-Tau Monoclonal Antibody for Alzheimer’s Disease Therapy

    Antibody inhibits Tau aggregation involved in the pathology of Alzheimer’s and other neurodegenerative diseases

    Read more

  • News releases

    MRC Technology and AstraZeneca renew collaboration to identify novel targets for discovery research

    The collaboration focuses on the identification and selection of novel drug targets with the potential to become potent and selective…

    Read more

  • News releases

    Dementia Consortium wins One Nucleus BioNewsRound Award at ON Helix 2014

    The award was given for the announcement of the formation of a £3m Dementia Consortium in collaboration with Alzheimer’s Research…

    Read more

WordPress development by Andy White using PorterWP